Technical Analysis for IMTX - Immatics N.V.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 7.80 | -0.13% | -0.01 |
IMTX closed down 0.13 percent on Wednesday, November 20, 2024, on approximately normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Down 3% | about 20 hours ago |
| 60 Minute Opening Range Breakdown | about 21 hours ago |
| Fell Below Previous Day's Low | about 21 hours ago |
| Down 2 % | about 21 hours ago |
| New 52 Week Low | about 21 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its clinical pipelines include adoptive cell therapy (ACT) and TCR biscpecifics (TCER™). Its therapeutic approaches are ACTengine, Next Generation ACT, and TCER. The company was founded on March 10, 2020 and is headquartered in Tuebingen, Germany.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Clinical Medicine Immune System Immunotherapy Cancer Treatment Treatment Of Cancer Cell Therapy Virotherapy Immunotherapies T Cell Adoptive Cell Transfer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Clinical Medicine Immune System Immunotherapy Cancer Treatment Treatment Of Cancer Cell Therapy Virotherapy Immunotherapies T Cell Adoptive Cell Transfer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 13.77 |
| 52 Week Low | 7.46 |
| Average Volume | 642,741 |
| 200-Day Moving Average | 11.21 |
| 50-Day Moving Average | 10.10 |
| 20-Day Moving Average | 8.89 |
| 10-Day Moving Average | 8.47 |
| Average True Range | 0.42 |
| RSI (14) | 21.26 |
| ADX | 33.43 |
| +DI | 7.69 |
| -DI | 32.91 |
| Chandelier Exit (Long, 3 ATRs) | 8.57 |
| Chandelier Exit (Short, 3 ATRs) | 8.72 |
| Upper Bollinger Bands | 10.03 |
| Lower Bollinger Band | 7.75 |
| Percent B (%b) | 0.02 |
| BandWidth | 25.65 |
| MACD Line | -0.57 |
| MACD Signal Line | -0.49 |
| MACD Histogram | -0.0815 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.45 | ||||
| Resistance 3 (R3) | 8.40 | 8.15 | 8.34 | ||
| Resistance 2 (R2) | 8.15 | 7.98 | 8.17 | 8.30 | |
| Resistance 1 (R1) | 7.97 | 7.88 | 8.06 | 8.02 | 8.27 |
| Pivot Point | 7.72 | 7.72 | 7.76 | 7.74 | 7.72 |
| Support 1 (S1) | 7.54 | 7.55 | 7.63 | 7.59 | 7.33 |
| Support 2 (S2) | 7.29 | 7.45 | 7.31 | 7.30 | |
| Support 3 (S3) | 7.11 | 7.29 | 7.26 | ||
| Support 4 (S4) | 7.16 |
